Oil prices are back in focus after Europe’s monthly petroleum bill rose by €10b compared with 2025, and higher fuel costs are feeding through to household and business budgets. When broad markets fixate on expensive ener
Why SNN Stock advanced +0.96% Today — RQD Quant Desk Flash
Smith & Nephew SNATS Inc. (SNN) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Why SNN Stock advanced +0.96% Today — RQD Quant Desk Flash
Smith & Nephew SNATS Inc. (SNN) advanced +0.96% to $30.41 as options desks priced 53% call premium vs. 47% put protection around the $30 max-pain magnet. Solid 41% profit margin (10% return on capital), mixed timing at 33x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 39% of its 52-week range ($26.12 – $37.09) with RSI-14 at 58 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $2.4M in bullish call flow vs. $2.1M in put flow (Put/Call 0.88x, implied earnings swing ±7%).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 41% gross margin and $281.4M annual free cash flow.
Johnson & Johnson (NYSE: JNJ) reported new oncology data, including a 75% tumor response rate for JNJ-6143 in advanced prostate cancer. The RYBREVANT FASPRO regimen produced a 77% response rate as an initial treatment op
European gas prices have surged to a four year high and the UK faces some of the highest energy costs in the region. When power and heating get expensive, companies that generate strong cash inflows can look more resilie
Merger breakdown puts Smith & Nephew in the spotlight The collapse of Johnson & Johnson's proposed merger with Smith & Nephew (LSE:SN.) after a leadership dispute keeps control with CEO Deepak Nath and leaves investors r
Smith & Nephew has delivered a 39.1% gain over the past three years, yet the real question for anyone looking at the stock today is how well that share price lines up with the cash the business can generate. With fresh h
Johnson & Johnson (JNJ:NYSE) shares closed down 1. 42% at $263.
Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index dropping 1.3% and
Healthcare stocks were lower Friday afternoon, with the NYSE Healthcare Index dropping 1.2% and the
Key Stats for Johnson & Johnson StockPrice change for Johnson & Johnson stock in last 6 months: 14%$JNJ Stock Price as of Oct. 22: $26752-Week High: $281$JNJ Stock Price Target: $279__Now Live: Discover how much upside y
The European stock markets closed lower in Friday trading as rising oil prices showed no sign of sto
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live SNN Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
SNN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on SNN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for SNN. Explore sector supply chains on /butterfly.
SNN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is SNN stock moving today?
Why SNN Stock advanced +0.96% Today — RQD Quant Desk Flash. Solid 41% profit margin (10% return on capital), mixed timing at 33x P/E—hold if owned, no rush to chase.